https://www.selleckchem.com/products/scr7.html
Purpose To evaluate whether antitumor immunity is enhanced by combining radiofrequency (RF) ablation and anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) therapy and to evaluate its effect on untreated tumors. Materials and methods First, 40 mice with tumors established in the bilateral flanks were randomly divided into 4 groups the control group, the RF ablation-alone group, the anti-CTLA-4-alone group, and the RF ablation + anti-CTLA-4 group. In each group, 8 mice were used for untreated tumor evaluation and survival observation
Curtir
Comentario
Compartilhar
